Скачать или смотреть From Drug Discovery to Product Release | Bioasia 2026 | Genotypic Technology

In this interview recorded at BioAsia 2026 in Hyderabad, Mr. Bharath Yoganarasimha Deputy Manager of Genotypic Technology, along with Dr. Saroja, discusses how genomics technologies are transforming the biopharmaceutical industry.

Genotypic Technology is a 28-year-old genomics company that has worked with leading pharma, biopharma, and FMCG organizations by providing advanced genomics solutions.

The company specializes in Next Generation Sequencing (NGS) and genomics-based testing solutions that support the entire pharmaceutical value chain, including:

• Drug discovery and biomolecule development
• Biomarker discovery
• Cell line characterization
• Insert characterization
• Adventitious agent testing
• Quality assurance and quality control (QA/QC) in biopharma

Genotypic Technology provides end-to-end solutions, starting from study design and project planning to data interpretation and post-project support. Their team includes experienced scientists and PhD researchers who work closely with clients to deliver comprehensive solutions for complex biopharma challenges.

With decades of experience and partnerships across India and globally, the company continues to drive innovation in genomics and support the evolving needs of the biopharmaceutical industry.

Subscribe for innovative and technology-based information from the biopharma and healthcare sector.

#BioAsia2026 #infocusrxtoday #Genotypictechnology #genomics #BiopHarma #Drugdiscovery #biomarkers